Royalty aggregators like Royalty Pharma, Ligand, and XOMA are revolutionizing biotech by providing upfront cash for R&D. Read ...

Discover Ligand Pharmaceuticals Inc's groundbreaking patent for compounds treating leukemia and hematopoietic disorders. Explore the versatile pharmaceutical compositions and potential applications ...

Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML ...

A month has gone by since the last earnings report for Ligand Pharmaceuticals (LGND). Shares have lost about 15.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

A new biopharmaceutical company is picking up where a Durham-based firm that went bankrupt last year left off. Pelthos Therapeutics was formed around the former assets of Novan, which was pursuing ...

DURHAM, N.C., April 03, 2024--(BUSINESS WIRE)--Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment ...

Cite this: Osteoprotegerin and its Ligand: A New Paradigm for Regulation of Osteoclastogenesis and Bone Resorption - Medscape - Mar 08, 2000. Dr. Aubin is Professor and Chair, Department of ...

PRESS RELEASECHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical ...